. Chapter,

, Clinical presentation of Acute coronary syndrome

, Management of coronary artery disease

, 3.1.5.3.3. Inhibitors of the renin-Angiotensin system

, Imaging study

, 3.2.5.1.1. General measures: stroke unit

, Antithrombotic and antiplatelets therapy

, Treatment of Hemorrhagic stroke

, 39 I.4.1. Definition and classification of cardiovascular risk factors

, Co-occurrence of risk factors

I. I. Chapter, . Epidemiology, and . .. Cardiovascular, 52 II.1. Cardiovascular disease in the world

, Cardiovascular risk factors in the world

, 63 healthcare centers are required for an accurate management

S. Mendis, P. Puska, B. Norrving, and W. H. Organization, Federation WH, Organization WS. Global atlas on cardiovascular disease prevention and control [Internet]. Geneva: World Health Organization, 2011.

, WHO. WHO | Cardiovascular diseases (CVDs), 2017.

E. J. Benjamin, M. J. Blaha, S. E. Chiuve, M. Cushman, S. R. Das et al., Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association, 2017.

, WHO | Cardiovascular diseases (CVDs) [Internet]. WHO, 2017.

, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study, GBD 2013 Mortality and Causes of Death Collaborators, vol.385, pp.117-71, 2013.

G. A. Roth, M. D. Huffman, A. E. Moran, V. Feigin, G. A. Mensah et al., Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation, vol.132, pp.1667-78, 2015.

A. Husseini, N. M. Abu-rmeileh, M. N. Ramahi, T. M. Ghosh, H. A. Barghuthi et al., Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory. The Lancet, vol.373, pp.1041-1050, 2009.

, World Health Statistics, 2011.

L. Zynia, A. C. The, . Burden-of, . In, . West et al., , 2000.

, Health conditions in the occupied Palestinian territory, including east Jerusalem, and in the occupied Syrian Golan, pp.2-59, 2016.

, Report WHO Expert. WHO | Waist circumference and waist-hip, 2008.

, ADA Diabetes Management Guidelines A1C Diagnosis | NDEI, 2016.

P. A. James, S. Oparil, B. L. Carter, W. C. Cushman, C. Dennison-himmelfarb et al., evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8), JAMA, vol.311, issue.5, pp.507-527, 2014.

, WHO hypertension. WHO | Q&As on hypertension

Y. Chen, X. Zhang, B. Pan, J. X. Yao, H. Chen et al., National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, vol.9, pp.3143-421, 2002.

, Epidemiology of coronary artery disease and stroke and risk factors in Gaza community, Palestine PLOS ONE, vol.9, issue.11, 2019.

G. Radaideh, N. Tzemos, T. M. Ali, Y. Eldershaby, J. Joury et al., Cardiovascular Risk Factor Burden in the United Arab Emirates (UAE): The Africa Middle East (AfME) Cardiovascular Epidemiological (ACE) Study Sub-analysis. Int Cardiovasc Forum, vol.11, 2017.

D. Kahan, Adult physical inactivity prevalence in the Muslim world: Analysis of 38 countries, Prev Med Rep, vol.2, pp.71-76, 2015.

R. M. Mabry, M. M. Reeves, E. G. Eakin, and N. Owen, Evidence of physical activity participation among men and women in the countries of the Gulf cooperation council: a review, Obes Rev Off J Int Assoc Study Obes, vol.11, issue.6, pp.457-64, 2010.

A. A. Saeed, N. A. Al-hamdan, A. , and A. H. , The prevalence of physical activity and its socioeconomic correlates in Kingdom of Saudi Arabia: A cross-sectional population-based national survey, 2015.

J. N. Hall, S. Moore, S. B. Harper, and J. W. Lynch, Epidemiology of coronary artery disease and stroke and risk factors in Gaza community, Palestine PLOS ONE, vol.36, issue.5, pp.402-409, 2009.

F. G. Fowkes, D. Rudan, I. Rudan, V. Aboyans, J. O. Denenberg et al., Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis, Lancet, vol.382, issue.13, pp.61249-61249, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00925590

E. J. Benjamin, M. J. Blaha, S. E. Chiuve, M. Cushman, S. R. Das et al.,

J. H. Wilkins, H. M. Wu, S. S. Alger, P. Wong, and O. Muntner, Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association, 2017.

K. Srivaratharajah and B. L. Abramson, Women and Peripheral Arterial Disease: A Review of Sex Differences in Epidemiology, Clinical Manifestation and Outcomes, Canadian Journal of Cardiology, 2018.

A. T. Hirsch, M. H. Criqui, D. Treat-jacobson, J. G. Regensteiner, M. A. Creager et al., Peripheral arterial disease detection, awareness, and treatment in primary care, JAMA, vol.286, pp.1317-1324, 2001.

J. E. Lewis, P. Williams, and J. H. Davies, Non-invasive assessment of peripheral arterial disease: Automated ankle brachial index measurement and pulse volume analysis compared to duplex scan, SAGE Open Med, vol.4, 2016.

F. G. Fowkes, G. D. Murray, I. Butcher, C. L. Heald, R. J. Lee et al., Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis, JAMA, vol.300, pp.197-208, 2008.

J. M. Murabito, J. C. Evans, M. G. Larson, K. Nieto, D. Levy et al., The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study, Arch. Intern. Med, vol.163, pp.1939-1942, 2003.

J. W. Olin and B. A. Sealove, Peripheral Artery Disease: Current Insight Into the Disease and Its Diagnosis and Management, The Internet Journal of Epidemiology, vol.85, pp.678-692, 2004.

L. Nguyen, D. R. Liles, P. H. Lin, and R. L. Bush, Hormone replacement therapy and peripheral vascular disease in women, Vasc Endovascular Surg, vol.38, pp.547-556, 2004.

V. Aboyans, M. H. Criqui, R. L. Mcclelland, M. A. Allison, M. M. Mcdermott et al., Intrinsic contribution of gender and ethnicity to normal ankle-brachial index values: the Multi-Ethnic Study of Atherosclerosis (MESA), J. Vasc. Surg, vol.45, pp.319-327, 2007.

A. S. Khan, M. Isik, T. Set, Z. Akturk, and U. Avsar, A 5-year trend of myocardial infarction, hypertension, stroke and diabetes mellitus in gender and different age groups in Erzurum, Turkey, Journal of Taibah University Medical Sciences, vol.9, pp.198-205, 2014.

W. B. Kannel, Fifty years of Framingham Study contributions to understanding hypertension, J Hum Hypertens, vol.14, pp.83-90, 2000.

F. G. Fowkes, E. Housley, R. A. Riemersma, C. C. Macintyre, E. H. Cawood et al., Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study, Am. J. Epidemiol, vol.135, pp.331-340, 1992.

V. C. Del-río, J. Mostaza, C. Lahoz, V. Sánchez-arroyo, C. Sabín et al.,

. Group, Prevalence of peripheral artery disease (PAD) and factors associated: An epidemiological analysis from the population-based Screening PRE-diabetes and type 2 DIAbetes (SPREDIA-2) study, PLOS ONE, vol.12, p.186220, 2017.

E. Selvin and T. P. Erlinger, Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, Circulation, vol.110, pp.738-743, 1999.

M. H. Criqui and V. Aboyans, Epidemiology of Peripheral Artery Disease, Circulation Research, vol.116, pp.1509-1526, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01233163

A. B. Newman, D. S. Siscovick, T. A. Manolio, J. Polak, L. P. Fried et al., Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group, Circulation, vol.88, pp.837-845, 1993.

. Caprie-steering-committee, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee, Lancet, vol.348, pp.1329-1339, 1996.

K. Ouriel, Peripheral arterial disease, Lancet, vol.358, pp.6351-6357, 2001.

P. P. Cacoub, M. T. Abola, I. Baumgartner, D. L. Bhatt, M. A. Creager et al., REACH Registry Investigators, Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry, Atherosclerosis, vol.204, pp.86-92, 2009.

P. Wilson, D. 'agostino, R. B. Parise, H. Sullivan, L. Meigs et al., Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

, , vol.112, pp.3066-3072

S. M. Grundy, Metabolic syndrome pandemic, Arterioscler Thromb Vasc Biol

, , vol.28, pp.629-636

K. G. Alberti, R. H. Eckel, and S. M. Grundy, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute, Circulation, vol.120, issue.16, pp.1640-1645, 2009.

K. Alberti, P. Zimmet, and J. Shaw, The metabolic syndrome--a new worldwide definition, Lancet Lond Engl, vol.366, issue.9491, pp.1059-1062, 2005.

M. P. Reilly and D. J. Rader, The metabolic syndrome: more than the sum of its parts?, Circulation, vol.108, issue.13, pp.1546-1551, 2003.

E. A. Andreadis, G. I. Tsourous, and C. K. Tzavara, Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population, Am J Hypertens, vol.20, issue.5, pp.558-564, 2007.

B. Balkau, J. E. Deanfield, and J. Després, International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168
URL : https://hal.archives-ouvertes.fr/inserm-00186711

, , vol.116, pp.1942-1951

A. Esteghamati, A. Zandieh, O. Khalilzadeh, A. Meysamie, and H. Ashraf, Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population, Diabetes Metab Syndr Clin Res Rev, vol.2, issue.2, pp.195-201, 2010.

H. A. Sliem, S. Ahmed, N. Nemr, and I. El-sherif,

J. Indian and . Metab, Sirdah MM, Al Laham NA, Abu Ghali AS. Prevalence of metabolic syndrome and associated socioeconomic and demographic factors among Palestinian adults, vol.16, pp.20-65, 2012.

, the Gaza Strip, vol.5, pp.93-97, 2011.

H. F. Abdul-rahim, A. Husseini, E. Bjertness, R. Giacaman, N. H. Gordon et al., The metabolic syndrome in the West Bank population: an urban-rural comparison, Diabetes Care, vol.24, issue.2, pp.275-279, 2001.

V. Aboyans, M. H. Criqui, and P. Abraham, Measurement and Interpretation of the
URL : https://hal.archives-ouvertes.fr/hal-00921590

, Ankle-Brachial Index: A Scientific Statement From the

K. G. Alberti, P. Zimmet, and J. Shaw, Metabolic syndrome--a new world-wide definition, Circulation, 2012.

, A Consensus Statement from the International Diabetes Federation, ADA Diabetes Management Guidelines A1C Diagnosis | NDEI, vol.23, pp.469-480, 2006.

P. A. James, S. Oparil, and B. L. Carter, 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8), 17. WHO hypertension. WHO | Q&As on hypertension, vol.311, pp.507-520, 2014.

N. Rizkallah, T. Marshall, and D. Kritz-silverstein, Parity and risk factors for coronary heart disease in Palestinian women in two refugee camps in the West Bank: a population based cross-sectional survey, Lancet, p.28, 2010.

S. G. Massad, M. Khalili, and W. Karmally, Metabolic Syndrome among Refugee Women from the West Bank, Palestine: A Cross-Sectional Study, Nutrients, vol.10, issue.8, 2018.

Y. Wang, E. B. Rimm, M. J. Stampfer, W. C. Willett, and F. B. Hu, Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men, Am J Clin Nutr, vol.81, issue.3, pp.555-563, 2005.

J. Shahwan, A. Abed, Y. Magne, and J. , Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study, The Lancet, vol.22, pp.1659-1724, 2015.

S. Aaron, Smartphone Use in 2015 | Pew Research Center, 2015.

Z. Abdeen, C. Jildeh, S. Dkeideek, and R. Qasrawi, Overweight and Obesity among Palestinian Adults: Analyses of the Anthropometric Data from the First National Health and Nutrition Survey, Journal of Obesity. Available from, 1999.

H. F. Abdul-rahim, A. Husseini, E. Bjertness, and R. Giacaman, The metabolic syndrome in the West Bank population: an urban-rural comparison, Diabetes Care, vol.24, issue.2, pp.275-279, 2001.

V. Aboyans, M. H. Criqui, P. Abraham, and M. A. Allison, Measurement and Interpretation of the Ankle-Brachial Index: A Scientific Statement From the American Heart Association. Circulation, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00921590

V. Aboyans, I. Desormais, P. Lacroix, and J. Salazar, The general prognosis of patients with peripheral arterial disease differs according to the disease localization, Journal of the American College of Cardiology, vol.55, issue.9, pp.898-903, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00605114

V. Aboyans and J. Ricco, The 2017 ESC Guidelines on PADs: what's new?, European Heart Journal, vol.39, issue.9, pp.720-729, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02042901

V. Aboyans, J. Ricco, M. E. Bartelink, and M. Björck, ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the, 2017.

, European Heart Journal. [Online], vol.39, issue.9, pp.763-816

J. Abrams, Chronic Stable Angina, JOURNAL OF MEDICINE, issue.24, p.2524, 2005.

H. F. Abukhdeir, L. S. Caplan, L. Reese, and E. Alema-mensah, Factors affecting the prevalence of chronic diseases in Palestinian people: an analysis of data from the Palestinian Central Bureau of Statistics. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq almutawassit, vol.19, pp.307-313, 2013.

B. Abuyassin and I. Laher, Diabetes epidemic sweeping the Arab world, World Journal of Diabetes, issue.8, pp.165-174, 2016.

, Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care, S13-S27. Available from, p.41, 2018.

, My Life Check -Life's Simple 7, AHA, 2016.

, Stress and Heart Health, AHA, vol.2014, p.22, 2014.

, Cardiovascular Disease & Diabetes, 2018.

M. Alarouj, A. Bennakhi, Y. Alnesef, and M. Sharifi, Diabetes and associated cardiovascular risk factors in the State of Kuwait: the first national survey, International Journal of Clinical Practice, vol.67, issue.1, pp.89-96, 2013.

K. G. Alberti, R. H. Eckel, S. M. Grundy, and P. Z. Zimmet, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute, vol.120, pp.1640-1645, 2009.

K. G. Alberti, P. Zimmet, and J. Shaw, Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation, Diabetic Medicine: A Journal of the British Diabetic Association, vol.23, issue.5, pp.469-480, 2006.

K. G. Alberti, P. Zimmet, and J. Shaw, International Diabetes Federation: a consensus on Type 2 diabetes prevention, Diabetic Medicine: A Journal of the British Diabetic Association. [Online], vol.24, issue.5, pp.451-463, 2007.

K. G. Alberti, P. Zimmet, and J. Shaw, The metabolic syndrome--a new worldwide definition, Lancet, pp.67402-67410, 2005.

M. K. Ali, K. M. Bullard, J. B. Saaddine, and C. C. Cowie, Achievement of goals in U.S. diabetes care, The New England Journal of Medicine, issue.17, pp.1613-1624, 1999.

N. Aljefree and F. Ahmed, Prevalence of Cardiovascular Disease and Associated Risk Factors among Adult Population in the Gulf Region: A Systematic Review. Advances in Public Health, 2015.

M. A. Allison, E. Ho, J. O. Denenberg, and R. D. Langer, Ethnic-specific prevalence of peripheral arterial disease in the United States, American Journal of Preventive Medicine, vol.32, issue.4, pp.328-333, 2007.

M. M. Al-nozha, M. R. Arafah, Y. Y. Al-mazrou, and M. A. Al-maatouq, Coronary artery disease in Saudi Arabia, Saudi Medical Journal, vol.25, issue.9, pp.1165-1171, 2004.

A. J. Al-quwaidhi, M. S. Pearce, E. Sobngwi, and J. A. Critchley, Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation and other modelling studies. Diabetes Research and Clinical Practice, vol.103, pp.496-503, 2014.

K. Al-rubeaan, H. A. Al-manaa, T. A. Khoja, and N. A. Ahmad, Epidemiology of abnormal glucose metabolism in a country facing its epidemic: SAUDI-DM study: ?? ??????????????????SAUDI-DM??, Journal of Diabetes, vol.7, issue.5, pp.622-632, 2015.

A. A. Alsheikh-ali, M. I. Omar, F. J. Raal, and W. Rashed, Cardiovascular Risk Factor Burden in Africa and the Middle East: The Africa Middle East Cardiovascular Epidemiological (ACE) Study. PLOS ONE, vol.9, 2014.

N. A. Alwan, A. Alwan, and S. Jabbour, Non-communicable diseases I: burden and approaches to prevention, 2012.

H. Alzahrani, D. Wang, B. Bakhotmah, and F. Hu, Risk factors for peripheral artery disease among patients with diabetes in Saudi Arabia, Vascular medicine, 2014.

J. A. Ambrose and R. S. Barua, The pathophysiology of cigarette smoking and cardiovascular disease: An update, Journal of the American College of Cardiology, issue.10, pp.1731-1737, 2004.

, ADA Diabetes Management Guidelines A1C Diagnosis | NDEI, p.22, 2016.

J. L. Anderson and D. A. Morrow, Acute myocardial infarction, The New England Journal of Medicine, issue.21, p.2053, 2017.

T. J. Anderson, J. Grégoire, R. A. Hegele, and P. Couture, 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. The Canadian Journal of Cardiology, Online], vol.29, issue.2, pp.151-167, 2013.

. Anon, Gaza Strip Joint Health Sector Assessment Report -September 2014 -occupied Palestinian territory

. Reliefweb, , 2018.

. Anon, IPAQ scoring protocol -International Physical Activity Questionnaire, 2005.

. Anon, Mobile Phone Interventions for the Secondary Prevention of Cardiovascular Disease, vol.58, pp.639-650, 2016.

. Anon, Palestine Health Status Annual Report 2017 | GHDx, 2019.

. Anon, Pathogenesis of atherosclerosis, vol.23, pp.473-478, 2017.

. Anon, National Institute of Diabetes and Digestive and Kidney Diseases, 2016.

. Anon, Sex differences in cardiovascular risk factors and disease prevention, pp.211-218, 2015.

. Anon, Stroke in the acute setting, vol.45, pp.163-168, 2017.

;. Anon and . Who-|-alcohol, , 2014.

. Anon, WHO | Global Health Observatory (GHO) data, p.10, 2012.

. Anon, WHO | Global recommendations on physical activity for health, 2018.

. Anon, WHO | Scaling up action against NCDs: How much will it cost, 2018.

. Anon, WHO | World Health Statistics 2017: Monitoring health for the SDGs

. Anon, WHO Regional Office for the Eastern Mediterranean, p.12, 2012.

. Anon, WHO/ISH cardiovascular risk prediction charts, 2007.

. Anon, World Health Statistics, 2011.

J. Aponte, The prevalence of peripheral arterial disease (PAD) and PAD risk factors among different ethnic groups in the US Population, Journal of Vascular Nursing, vol.30, issue.2, pp.37-43, 2012.

E. Archer and S. N. Blair, Physical activity and the prevention of cardiovascular disease: from evolution to epidemiology. Progress in Cardiovascular Diseases, vol.53, pp.387-396, 2011.

E. A. Ashley and J. Niebauer, Coronary artery disease, 2004.

. Remedica, , 2018.

G. Assmann, H. Schulte, A. Von-eckardstein, and Y. Huang, High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport, Atherosclerosis, vol.124, 1996.

P. P. Aung, H. G. Maxwell, R. G. Jepson, and J. F. Price, Lipid-lowering for peripheral arterial disease of the lower limb. The Cochrane Database of Systematic Reviews, 2007.

H. Ay, T. Benner, E. M. Arsava, and K. L. Furie, A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke, vol.38, pp.2979-2984, 2007.

H. Ay, K. L. Furie, A. Singhal, and W. S. Smith, An evidence-based causative classification system for acute ischemic stroke, Annals of Neurology, vol.58, issue.5, pp.688-697, 2005.

C. Baigent, A. Keech, P. M. Kearney, and L. Blackwell, Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, vol.366, issue.9493, pp.67394-67395, 2005.

D. Bainton, P. Sweetnam, I. Baker, and P. Elwood, Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Heart, Online], vol.72, issue.2, pp.128-132, 1994.

H. Ben-romdhane, S. B. Ali, W. Aissi, and P. Traissac, Prevalence of diabetes in Northern African countries: the case of Tunisia, vol.14, 2014.

H. T. Benamer and D. Grosset, Stroke in Arab countries: A systematic literature review, Journal of the Neurological Sciences, vol.284, issue.1-2, pp.18-23, 2009.

E. J. Benjamin, M. J. Blaha, S. E. Chiuve, and M. Cushman, Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation, 2017.

B. Emelia, J. Virani-salim, S. Callaway-clifton, W. Chamberlain, and A. M. , Update: A Report From the American Heart Association. Circulation. [Online], vol.137, issue.12, pp.67-492, 2018.

J. S. Berger, C. O. Jordan, D. Lloyd-jones, and R. S. Blumenthal, Screening for Cardiovascular Risk in Asymptomatic Patients, Journal of the American College of Cardiology, vol.55, issue.12, pp.1169-1177, 2010.

K. Bergmann, Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk, EJIFCC, vol.21, issue.3, pp.64-67, 2010.

, Best Buys' to prevent noncommunicable diseases, 'Best Buy'WHO, 2014.

J. W. Beulens, A. Algra, S. S. Soedamah-muthu, and F. L. Visseren, Alcohol consumption and risk of recurrent cardiovascular events and mortality in patients with clinically manifest vascular disease and diabetes mellitus: the Second Manifestations of ARTerial (SMART) disease study. Atherosclerosis, vol.212, pp.281-286, 2010.

P. Bhatnagar, K. Wickramasinghe, E. Wilkins, and N. Townsend, Trends in the epidemiology of cardiovascular disease in the UK. Heart, vol.102, pp.1945-1952, 2016.

P. Bhatnagar, K. Wickramasinghe, J. Williams, and M. Rayner, The epidemiology of cardiovascular disease in the UK 2014, 2015.

Z. Biloglav, . Biloglav, and . Zrinka, Performance of WHO Angina Questionnaire in measuring burden of coronary heart disease in human isolate populations, Recherche Google, vol.28, pp.738-62, 2004.

D. E. Bloom, E. Cafiero, E. Jané-llopis, and S. Abrahams-gessel, The Global Economic Burden of Noncommunicable Diseases, p.29, 2012.

C. J. Boushey, S. A. Beresford, G. S. Omenn, and A. G. Motulsky, A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease: Probable Benefits of Increasing Folic Acid Intakes, JAMA, vol.274, issue.13, pp.1049-1057, 1995.

A. D. Bowery, . Bowery, and D. K. Ashna, The Burden of Cardiovascular Disease in Lowand Middle-Income Countries: Epidemiology and Management, Recherche Google, vol.31, pp.738-62, 2015.

E. J. Boyko, M. Courten, . De, P. Z. Zimmet, and P. Chitson, Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius. Diabetes Care, vol.23, pp.1242-1248, 2000.

E. Braunwald, R. H. Jones, D. B. Mark, and J. Brown, Diagnosing and managing unstable angina. Agency for Health Care Policy and Research, Circulation, vol.90, issue.1, pp.613-622, 1994.

S. E. Brien, P. E. Ronksley, B. J. Turner, and K. J. Mukamal, Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies, BMJ, 2011.

J. Broderick, S. Connolly, E. Feldmann, and D. Hanley, Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation, vol.116, 2007.

D. J. Brotman, S. H. Golden, and I. S. Wittstein, The cardiovascular toll of stress, Lancet, pp.61305-61306, 2007.

R. A. Brown, E. Shantsila, C. Varma, and G. Y. Lip, Current Understanding of Atherogenesis, The American Journal of Medicine, vol.130, issue.3, pp.268-282, 2017.

D. M. Burns, Epidemiology of smoking-induced cardiovascular disease, vol.46, pp.79-82, 2003.

P. P. Cacoub, M. T. Abola, I. Baumgartner, and D. L. Bhatt, Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis, Online], vol.204, issue.2, pp.86-92, 2009.

K. Cahill, S. Stevens, R. Perera, and T. Lancaster, Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database of Systematic Reviews, 2013.

C. P. Cannon, Cardiovascular disease and modifiable cardiometabolic risk factors, Clinical cornerstone, vol.9, issue.2, pp.24-41, 2008.

D. Canoy and I. Buchan, d.) Challenges in obesity epidemiology, Obesity Reviews, vol.8, issue.s1, pp.1-11

, Centers for Disease Control and Prevention. cause of death 1999-2014 -Recherche Google, CDC, p.29, 2016.

, Electronic Nicotine Delivery Systems: Key Facts from the CDC | Access Health, CDC, 2016.

, National Diabetes Statistics Report | Data & Statistics | Diabetes | CDC, CDC, 2018.

, NHIS -Adult Tobacco Use -Glossary, CDC, vol.29, 2017.

Y. Chen, X. Zhang, B. Pan, and X. Jin, A modified formula for calculating low-density lipoprotein cholesterol values. Lipids in Health and Disease, vol.9, 2010.

S. Cheng, H. Yu, Y. Chen, and C. Chen, Physical Activity and Risk of Cardiovascular Disease Among Older Adults, International Journal of Gerontology, vol.7, issue.3, pp.133-136, 2013.

R. Chetty, M. Stepner, S. Abraham, and S. Lin, The Association Between Income and Life Expectancy in the United States, JAMA, issue.16, pp.1750-1766, 2001.

A. Chockalingam, I. Balaguer-vintro, A. Achutti, and A. B. De-luna, The World Heart Federation's white book: impending global pandemic of cardiovascular diseases: challenges and opportunities for the prevention and control of cardiovascular diseases in developing countries and economies in transition, The Canadian Journal of Cardiology, vol.16, issue.2, pp.227-229, 2000.

J. Choi, S. S. Daskalopoulou, G. Thanassoulis, and I. Karp, Sex-and gender-related risk factor burden in patients with premature acute coronary syndrome. The Canadian Journal of Cardiology, vol.30, pp.109-117, 2014.

L. Choudhury and J. D. Marsh, Myocardial infarction in young patients, The American Journal of Medicine, vol.107, issue.3, pp.254-261, 1999.

C. K. Chow, N. Ariyarathna, S. M. Islam, and A. Thiagalingam, mHealth in Cardiovascular Health Care. Heart, Lung & Circulation, pp.802-807, 2016.

C. K. Chow, S. Islam, L. Bautista, and Z. Rumboldt, Parental history and myocardial infarction risk across the world: the INTERHEART Study, Journal of the American College of Cardiology. [Online], vol.57, issue.5, pp.619-627, 2011.

C. K. Chow, J. Redfern, G. S. Hillis, and J. Thakkar, Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease: A Randomized Clinical Trial, JAMA, issue.12, pp.1255-1263, 2015.

C. K. Chow, K. K. Teo, S. Rangarajan, and S. Islam, Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries, JAMA, vol.310, issue.9, pp.959-968, 2013.

. Cia, CIA-The World Factbook-Gaza Strip, 2018.

S. Cohen, T. Kamarck, and R. Mermelstein, A global measure of perceived stress, Journal of Health and Social Behavior, vol.24, issue.4, pp.385-396, 1983.

M. T. Cooney, E. Vartiainen, T. Laatikainen, and D. De-bacquer, Cardiovascular risk age: concepts and practicalities. Heart (British Cardiac Society), vol.98, pp.941-946, 2012.

E. Costa, A. Santos-silva, C. Paúl, and J. González-gallego, Aging and Cardiovascular Risk, BioMed Research International. Available from, 2015.

C. Counsell, S. Boonyakarnkul, M. Dennis, and P. Sandercock, Primary Intracerebral Haemorrhage in the Oxfordshire Community Stroke Project. Cerebrovascular Diseases, vol.5, pp.26-34, 1995.

F. Crea, P. G. Camici, R. D. Caterina, and G. A. Lanza, Chronic Ischaemic Heart Disease, 2010.

, , 2018.

M. H. Criqui and V. Aboyans, Epidemiology of Peripheral Artery Disease. Circulation Research, vol.116, pp.1509-1526, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01233163

J. A. Critchley and S. Capewell, Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review, JAMA, vol.290, issue.1, pp.86-97, 2003.

F. J. Cronin, S. M. Krebs-smith, B. W. Wyse, and L. Light, Characterizing food usage by demographic variables, Journal of the American Dietetic Association, vol.81, issue.6, pp.661-673, 1982.

J. D. Curb, K. Masaki, B. L. Rodriguez, and R. D. Abbott, Peripheral artery disease and cardiovascular risk factors in the elderly. The Honolulu Heart Program. Arteriosclerosis, Thrombosis, and Vascular Biology, vol.16, pp.1495-1500, 1996.

R. B. D'agostino, S. Grundy, L. M. Sullivan, and P. Wilson, Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation, JAMA, vol.286, issue.2, pp.180-187, 2001.

R. B. D'agostino, M. J. Pencina, J. M. Massaro, and S. Coady, Cardiovascular Disease Risk Assessment: Insights from Framingham. Global Heart, vol.8, pp.11-23, 2013.

R. B. D'agostino, R. S. Vasan, M. J. Pencina, and P. A. Wolf, General Cardiovascular Risk Profile for Use in Primary Care. Circulation, vol.117, pp.743-753, 2008.

R. B. D'agostino-sr, M. J. Pencina, J. M. Massaro, and S. Coady, Cardiovascular Disease Risk Assessment: Insights from Framingham. Global Heart, vol.8, pp.11-23, 2013.

B. Dahlöf, Cardiovascular disease risk factors: epidemiology and risk assessment. The American Journal of Cardiology, 3A-9A. Available from, p.105, 2010.

J. Danesh, R. Collins, R. Peto, and G. D. Lowe, Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease, European Heart Journal. [Online], vol.21, issue.7, pp.515-520, 2000.

G. A. Diamond, A clinically relevant classification of chest discomfort, Journal of the American College of Cardiology, vol.1, issue.2, pp.574-575, 1983.

C. Diehm, J. R. Allenberg, D. Pittrow, and M. Mahn, Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation, vol.120, pp.2053-2061, 2009.

H. H. Ditschuneit, M. Flechtner-mors, and G. Adler, Fibrinogen in obesity before and after weight reduction, Obesity Research, vol.3, issue.1, pp.43-48, 1995.

J. T. Doyle, T. R. Dawber, W. B. Kannel, and A. S. Heslin, Cigarette Smoking and Coronary Heart Disease, New England Journal of Medicine, vol.266, issue.16, pp.796-801, 1962.

S. Dugani and T. A. Gaziano, 25 by 25: Achieving Global Reduction in Cardiovascular Mortality, Current Cardiology Reports, vol.18, issue.1, 2016.

J. D. Easton, J. L. Saver, G. W. Albers, and M. J. Alberts, Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists, pp.2276-2293, 2009.

R. H. Eckel, J. M. Jakicic, J. D. Ard, and J. M. De-jesus, AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, vol.25, pp.76-99, 2013.

K. M. Eggers, J. Oldgren, A. Nordenskjöld, and B. Lindahl, Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction, American Heart Journal. [Online], vol.148, issue.4, pp.574-581, 2004.

M. Elasmi, M. Feki, H. Sanhaji, and R. Jemaa, Prévalence des facteurs de risque cardiovasculaires conventionnels dans la population du Grand Tunis. /data/revues/03987620/v57i2/S0398762009000297, 2009.

A. Elis and M. Lishner, Composition of risk factors among acute myocardial infarction patients in Israel: sub-analysis of the Israeli National Prospective Survey on Acute Myocardial, 2004.

, Harefuah, vol.143, issue.7, p.550

A. Elis, D. Pereg, A. Tirosh, and T. Shochat, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology, vol.15, issue.3, pp.325-328, 2008.

A. El-menyar, J. Suwaidi, and H. Al-thani, Peripheral arterial disease in the Middle East: Underestimated predictor of worse outcome. Global Cardiology Science & Practice, Online], vol.2013, issue.2, pp.98-113, 2013.

J. Emberson, K. R. Lees, P. Lyden, and L. Blackwell, Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials, Lancet, vol.384, issue.9958, pp.60584-60589, 2014.

M. Eriksen, J. Mackay, and H. Ross, The Tobacco Atlas, 2013.

R. Esc, L. Grant, P. J. Anker, and S. D. , ESC Guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD), European Heart Journal, vol.34, issue.39, pp.3035-3087, 2013.

D. Escudero-augusto, L. Marqués-alvarez, and F. Taboada-costa, , 2008.

, Medicina Intensiva, vol.32, issue.6, pp.282-295

D. Ettehad, C. A. Emdin, A. Kiran, and S. G. Anderson, Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and metaanalysis, Lancet, pp.957-967, 2016.

, European Cardiovascular Disease Statistics, p.2012, 2012.

, European Cardiovascular Disease Statistics, p.16, 2012.

W. Fan, Epidemiology in diabetes mellitus and cardiovascular disease. Cardiovascular Endocrinology, vol.6, pp.8-16, 2017.

N. Fang, M. Jiang, and Y. Fan, Ideal cardiovascular health metrics and risk of cardiovascular disease or mortality: A meta-analysis, International Journal of Cardiology, vol.214, pp.279-283, 2016.

R. Farah, R. K. Zeidan, M. N. Chahine, and R. Asmar, Prevalence of stroke symptoms among stroke-free residents: first national data from Lebanon, International Journal of Stroke, vol.10, issue.SA100, pp.83-88, 2015.

D. S. Feig, B. Zinman, X. Wang, M. D. Hux, and J. E. , Risk of development of diabetes mellitus after diagnosis of gestational diabetes, CMAJ : Canadian Medical Association Journal. [Online], vol.179, issue.3, pp.229-234, 2008.

V. L. Feigin, B. Norrving, and G. A. Mensah, Global Burden of Stroke. Circulation Research, vol.120, issue.3, pp.439-448, 2017.

V. L. Feigin, G. A. Roth, M. Naghavi, and P. Parmar, Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet Neurology, vol.15, pp.30073-30077, 2016.

T. A. Gaziano, C. R. Young, G. Fitzmaurice, and S. Atwood, Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. The Lancet, pp.923-931, 2008.

, Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study, GBD 2015 Risk Factors Collaborators, pp.31679-31687, 2015.

, Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study, GBD 2016 Causes of Death Collaborators, pp.32152-32161, 2016.

A. A. Gehani, A. T. Al-hinai, M. Zubaid, and W. Almahmeed, Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study, European Journal of Preventive Cardiology, vol.21, issue.4, pp.400-410, 2014.

M. D. Gerhard-herman, H. L. Gornik, C. Barrett, and N. R. Barshes, AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, Journal of the American College of Cardiology, issue.11, pp.1465-1508, 2016.

R. Gerloni, L. Mucci, T. Ciarambino, and M. Ventura, Management of stable coronary artery disease: from evidence to clinical practice, Italian Journal of Medicine, vol.11, issue.2, pp.114-133, 2017.

R. Giacaman, R. Khatib, L. Shabaneh, and A. Ramlawi, Health status and health services in the occupied Palestinian territory, The Lancet, vol.373, issue.9666, pp.837-849, 2009.

K. W. Giang, L. Björck, S. Nielsen, and M. Novak, Twenty-year trends in long-term mortality risk in 17,149 survivors of ischemic stroke less than 55 years of age. Stroke, pp.3338-3343, 2013.

G. A. Giovino, S. A. Mirza, J. M. Samet, and P. C. Gupta, Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys, The Lancet, vol.380, issue.9842, pp.668-679, 2012.

D. Giugliano, M. I. Maiorino, G. Bellastella, and K. Esposito, Type 2 diabetes and cardiovascular prevention: the dogmas disputed. Endocrine, vol.60, pp.224-228, 2018.

D. C. Goff, D. M. Lloyd-jones, G. Bennett, and S. Coady, ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, S49-S73. Available from, vol.25, p.129, 2013.

U. Goldbourt, S. Yaari, and J. H. Medalie, Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.17, issue.1, pp.107-113, 1997.

D. J. Gordon, J. L. Probstfield, R. J. Garrison, and J. D. Neaton, High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies, Circulation, vol.79, issue.1, pp.8-15, 1989.

I. Graham, D. Atar, K. Borch-johnsen, and G. Boysen, European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts), European Heart Journal, vol.28, issue.19, pp.2375-2414, 2007.

A. Grainger-gasser, P. Perel, L. Lagier-hässig, and D. Wood, The Road to 25×25: Update on WHF CVD Roadmaps. Global Heart, vol.12, pp.269-270, 2017.

. Guy-de and . Backer, Prevention of cardiovascular disease: recent achievements and remaining challeng, 2017.

C. M. Hales, M. D. Carroll, C. D. Fryar, and C. L. Ogden, Prevalence of Obesity Among Adults and Youth: United States, pp.1-8, 2015.

S. J. Hamilton, B. Mills, E. M. Birch, and S. C. Thompson, Smartphones in the secondary prevention of cardiovascular disease: a systematic review, BMC Cardiovascular Disorders, 2018.

C. W. Hamm, C. Heeschen, E. Falk, and K. A. Fox, Acute Coronary Syndromes: Pathophysiology, Diagnosis and Risk Stratification, p.12, 2006.

G. J. Hankey and C. P. Warlow, Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations, Lancet, vol.354, issue.9188, pp.1457-1463, 1999.

E. Hawe, P. J. Talmud, G. J. Miller, and S. E. Humphries, Family history is a coronary heart disease risk factor in the second Northwick Park Heart Study, ANN HUM GENET, vol.67, pp.97-106, 2003.

T. He, X. Liu, N. Xu, and Y. Li, Diagnostic models of the pre-test probability of stable coronary artery disease: A systematic review, Clinics, vol.72, issue.2, pp.188-196, 2017.

N. C. Health, C. D. , and H. P. , US) O. on S. and (2014) Cardiovascular Diseases

, Centers for Disease Control and Prevention (US). Available from, 2018.

, Heart and Stroke Foundation of Canada (2014) Health eTools, 2014.

P. A. Heidenreich, J. G. Trogdon, O. A. Khavjou, and J. Butler, Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation, vol.123, pp.933-944, 2011.

J. Heinrich, L. Balleisen, H. Schulte, and G. Assmann, Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men, Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, vol.14, issue.1, pp.54-59, 1994.

A. D. Hendrani, T. Adesiyun, R. Quispe, and S. R. Jones, Dyslipidemia management in primary prevention of cardiovascular disease: Current guidelines and strategies, World Journal of Cardiology, vol.8, issue.2, pp.201-210, 2016.

W. R. Hiatt, S. Hoag, and R. F. Hamman, Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study, Circulation, vol.91, issue.5, pp.1472-1479, 1995.

A. T. Hirsch, M. H. Criqui, D. Treat-jacobson, and J. G. Regensteiner, Peripheral arterial disease detection, awareness, and treatment in primary care, JAMA, vol.286, issue.11, pp.1317-1324, 2001.

A. T. Hirsch, Z. J. Haskal, N. R. Hertzer, and C. W. Bakal, Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery,* Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation, vol.113, pp.463-654, 2005.

S. C. Hitchman and G. T. Fong, Gender empowerment and female-to-male smoking prevalence ratios, vol.89, pp.195-202, 2011.

J. D. Hooi, A. D. Kester, H. E. Stoffers, and M. M. Overdijk, Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study, American Journal of Epidemiology, vol.153, issue.7, pp.666-672, 2001.

J. D. Hooi, H. E. Stoffers, A. D. Kester, and P. E. Rinkens, Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease, Scandinavian Journal of Primary Health Care, vol.16, issue.3, pp.177-182, 1998.

R. S. Howard, The management of ischaemic stroke. Anaesthesia & Intensive Care Medicine, vol.17, pp.591-595, 2016.

H. B. Hubert, M. Feinleib, P. M. Mcnamara, and W. P. Castelli, Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study, Circulation, vol.67, issue.5, pp.968-977, 1983.

S. C. Hunt, M. Gwinn, and T. D. Adams, Family history assessment: strategies for prevention of cardiovascular disease, American Journal of Preventive Medicine, vol.24, issue.2, pp.136-142, 2003.

D. J. Hunter and K. S. Reddy, Noncommunicable Diseases, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01358549

A. Husseini, N. M. Abu-rmeileh, N. Mikki, and T. M. Ramahi, Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory. The Lancet, vol.373, pp.60109-60113, 2009.

R. Huxley, F. Barzi, and M. Woodward, Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies, BMJ, vol.332, issue.7533, pp.73-78, 2006.

R. R. Huxley and M. Woodward, Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies, Lancet, issue.11, pp.60781-60783, 2011.

, International Diabetes Federation, IDF 2009 (n.d.) International Diabetes Federation. IDF Diabetes Atlas, 2009.

. Diabetes%20atlas%204th%20edition and . Pdf, Recherche Google, 2014.

, IDF 2015 (2015) NTERNATIONAL DIABETIC FEDERATION

I. Ö. Ingolfsson, G. Sigurdsson, H. Sigvaldason, and G. Thorgeirsson, A marked decline in the prevalence and incidence of intermittent claudication in icelandic men 1968-1986: A strong relationship to smoking and serum cholesterol-The Reykjavik study, Journal of Clinical Epidemiology, vol.47, issue.11, pp.1237-1243, 1994.

M. Inoue, C. Nagata, I. Tsuji, and Y. Sugawara, Impact of alcohol intake on total mortality and mortality from major causes in Japan: a pooled analysis of six large-scale cohort studies, Journal of Epidemiology and Community Health, vol.66, issue.5, pp.448-456, 2012.

S. M. Islam, T. D. Purnat, N. T. Phuong, and U. Mwingira, Non-Communicable Diseases (NCDs) in developing countries: a symposium report. Globalization and Health, p.25, 2014.

S. Jabbour and R. Yamout, Public Health in the Arab World, 2012.

P. A. James, S. Oparil, B. L. Carter, and W. C. Cushman, evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8), JAMA, issue.5, pp.507-520, 2014.

P. S. Jellinger, Y. Handelsman, P. D. Rosenblit, and Z. T. Bloomgarden, Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, issue.23, pp.1-87, 2017.

M. M. Joosten, J. K. Pai, M. L. Bertoia, and E. B. Rimm, Associations between Conventional Cardiovascular Risk Factors and Risk of Peripheral Artery Disease in Men, JAMA : the journal of the American Medical Association, vol.308, issue.16, pp.1660-1667, 2012.

J. Joseph, A. Velasco, F. G. Hage, and E. Reyes, Guidelines in review: Comparison of ESC and ACC/AHA guidelines for the diagnosis and management of patients with stable coronary artery disease, Journal of Nuclear Cardiology, vol.25, issue.2, pp.509-515, 2018.

K. J. Joshipura, A. Ascherio, J. E. Manson, and M. J. Stampfer, Fruit and vegetable intake in relation to risk of ischemic stroke, JAMA, vol.282, issue.13, pp.1233-1239, 1999.

K. J. Joshipura, F. B. Hu, J. E. Manson, and M. J. Stampfer, The effect of fruit and vegetable intake on risk for coronary heart disease, Annals of Internal Medicine, vol.134, issue.12, pp.1106-1114, 2001.

S. Julius, S. D. Nesbitt, B. M. Egan, and M. A. Weber, Feasibility of treating prehypertension with an angiotensin-receptor blocker, The New England Journal of Medicine, vol.354, issue.16, pp.1685-1697, 2006.

W. B. Kannel, T. R. Dawber, A. Kagan, and N. Revotskie, Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study, Annals of Internal Medicine, vol.55, pp.33-50, 1961.

W. B. Kannel and P. Sorlie, Some health benefits of physical activity. The Framingham Study, Archives of Internal Medicine, vol.139, issue.8, pp.857-861, 1979.

W. B. Kannel and R. S. Vasan, Is Age Really a Non-modifiable Cardiovascular Risk Factor? The American journal of cardiology, vol.104, pp.1307-1310, 2009.

W. B. Kannel and . Wilson-pwf, Chapter B81. Cardiovascular risk factors and hypertension, Hypertension Primer, 2003.

S. L. Kardia, S. M. Modell, and P. A. Peyser, Family-centered approaches to understanding and preventing coronary heart disease, American Journal of Preventive Medicine, vol.24, issue.2, pp.143-151, 2003.

J. Kaur, A Comprehensive Review on Metabolic Syndrome. Cardiology Research and Practice, 2014.

P. M. Kearney, M. Whelton, K. Reynolds, and P. Muntner, Global burden of hypertension: analysis of worldwide data, Lancet, vol.365, issue.9455, pp.17741-17742, 2005.

O. Khatib, Noncommunicable diseases: risk factors and regional strategies for prevention and care, vol.10, pp.778-788, 2004.

P. Kirchhof, S. Benussi, D. Kotecha, and A. Ahlsson, ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, vol.18, pp.1609-1678, 2016.

B. M. Kissela, J. C. Khoury, K. Alwell, and C. J. Moomaw, Age at stroke: temporal trends in stroke incidence in a large, biracial population, pp.1781-1787, 2012.

M. Kivimäki and A. Steptoe, Effects of stress on the development and progression of cardiovascular disease, Nature Reviews Cardiology, vol.15, issue.4, pp.215-229, 2018.

A. L. Klatsky, Alcohol and cardiovascular diseases: where do we stand today, Journal of Internal Medicine, 2015.

V. Kontis, C. D. Mathers, J. Rehm, and G. A. Stevens, Contribution of six risk factors to achieving the 25×25 non-communicable disease mortality reduction target: a modelling study, Lancet, vol.384, issue.9941, pp.427-437, 2014.

S. Korff, H. A. Katus, and E. Giannitsis, Differential diagnosis of elevated troponins. Heart (British Cardiac Society), pp.987-993, 2006.

K. Kotseva, D. Wood, D. De-bacquer, and G. De-backer, EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries, European Journal of Preventive Cardiology, issue.6, pp.636-648, 2016.

R. V. Krishnamurthi, V. L. Feigin, M. H. Forouzanfar, and G. A. Mensah, Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. The Lancet Global Health, vol.1, pp.259-281, 2013.

I. J. Kullo and L. T. Cooper, Early identification of cardiovascular risk using genomics and proteomics. Nature reviews. Cardiology, pp.309-317, 2010.

A. Kulshreshtha, V. Vaccarino, S. E. Judd, and V. J. Howard, Life's Simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke, pp.1909-1914, 2013.

A. Kumar and C. P. Cannon, Acute Coronary Syndromes: Diagnosis and Management, Part II, vol.84, pp.1021-1036, 2009.

D. Labarthe, Epidemiology And Prevention Of Cardiovascular Diseases: A Global Challenge. 2 edition, 2010.

D. T. Lackland, E. J. Roccella, A. F. Deutsch, and M. Fornage, d.) Factors Influencing the Decline in Stroke Mortality: A Statement From the, American Heart Association/American Stroke Association. Stroke, vol.45, issue.1, pp.315-353

N. Lahoud, P. Salameh, N. Saleh, and H. Hosseini, Prevalence of Lebanese stroke survivors: A comparative pilot study, Journal of Epidemiology and Global Health, vol.6, issue.3, pp.169-176, 2016.

F. C. Lampe, P. H. Whincup, S. G. Wannamethee, and S. Ebrahim, Chest pain on questionnaire and prediction of major ischaemic heart disease events in men, European Heart Journal, vol.19, issue.1, pp.63-73, 1998.

A. Langsted and B. G. Nordestgaard, Nonfasting versus fasting lipid profile for cardiovascular risk prediction, Pathology, vol.51, issue.2, pp.131-141, 2019.

M. R. Law, N. J. Wald, and S. G. Thompson, By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?, Clinical research ed.), vol.308, issue.6925, pp.367-372, 1994.

C. D. Lee, A. R. Folsom, and S. N. Blair, Physical activity and stroke risk: a meta-analysis. Stroke, vol.34, pp.2475-2481, 2003.

B. M. Leon and T. M. Maddox, Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research, World Journal of Diabetes, vol.6, issue.13, pp.1246-1258, 2015.

G. Leonarda and L. Gabriella, Gender di erences in cardiovascular disease, Journal of Integrative Cardiology, pp.20-22, 2015.

P. J. Levy, Epidemiology and pathophysiology of peripheral arterial disease, Clinical Cornerstone, vol.4, issue.5, pp.1-13, 2002.

D. Liao, R. Myers, S. Hunt, and E. Shahar, Familial history of stroke and stroke risk. The Family Heart Study, Stroke, vol.28, issue.10, pp.1908-1912, 1997.

S. Liu, I. M. Lee, U. Ajani, and S. R. Cole, Intake of vegetables rich in carotenoids and risk of coronary heart disease in men: The Physicians' Health Study, International Journal of Epidemiology, vol.30, issue.1, pp.130-135, 2001.

D. Lloyd-jones, R. Adams, M. Carnethon, and G. De-simone, Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, vol.119, pp.21-181, 2009.

D. M. Lloyd-jones, M. G. Larson, A. Beiser, and D. Levy, Lifetime risk of developing coronary heart disease, Lancet, vol.353, issue.9147, pp.10279-10288, 1999.

R. Louis, C. Scot, E. , and K. , Etiology, classification, and epidemiology of stroke, 2018.

G. D. Lowe, Fibrinogen and Cardiovascular Disease: Historical Introduction, European Heart Journal, 1995.

N. Lowres, L. Neubeck, G. Salkeld, and I. Krass, Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thrombosis and Haemostasis, Online], vol.111, issue.6, pp.1167-1176, 2014.

R. Lozano, M. Naghavi, K. Foreman, and S. Lim, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet, vol.380, pp.2095-2128, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00827612

A. Luke, Are we facing a noncommunicable disease pandemic? -ScienceDirect, p.25, 2017.

A. J. Lusis, Atherosclerosis, Nature. Available from, vol.14, 2000.

A. Majeed, A. A. El-sayed, T. Khoja, and R. Alshamsan, Diabetes in the Middle-East and North Africa: an update. Diabetes Research and Clinical Practice, Online], vol.103, issue.2, pp.218-222, 2014.

A. Mandil, M. Chaaya, and D. Saab, Health status, epidemiological profile and prospects: Eastern Mediterranean region, International Journal of Epidemiology, vol.42, issue.2, pp.616-626, 2013.

T. A. Manolio, T. A. Pearson, N. K. Wenger, and E. Barrett-connor, Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop, Annals of Epidemiology, vol.2, issue.1-2, pp.161-176, 1992.

J. E. Manson, Prevention of myocardial infarction, p.15, 1996.

A. A. Mansour, A. A. Al-maliky, B. Kasem, and A. Jabar, Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol.7, pp.139-144, 2014.

M. E. Marenberg, N. Risch, L. F. Berkman, and B. Floderus, Genetic susceptibility to death from coronary heart disease in a study of twins, The New England Journal of Medicine, vol.330, issue.15, pp.1041-1046, 1994.

H. Markus, Stroke: causes and clinical features, Medicine, vol.44, issue.9, pp.515-520, 2016.

S. S. Martin, D. I. Feldman, R. S. Blumenthal, and S. R. Jones, mActive: A Randomized Clinical Trial of an Automated mHealth Intervention for Physical Activity Promotion, Journal of the American Heart Association, issue.11, p.4, 2015.

J. A. Marx, R. S. Hockberger, and R. M. Walls, Rosen's Emergency Medicine: Concepts and Clinical Practice, Sixth Edition, 3 volume set, 2006.

A. S. Matheus, M. De, L. R. Tannus, R. A. Cobas, and C. C. Palma, Impact of Diabetes on Cardiovascular Disease: An Update, International Journal of Hypertension. Available from, 2013.

W. Maziak, The global epidemic of waterpipe smoking, Addictive Behaviors, vol.36, issue.1-2, pp.1-5, 2011.

W. Maziak, R. Nakkash, R. Bahelah, and A. Husseini, Tobacco in the Arab world: old and new epidemics amidst policy paralysis. Health Policy and Planning, Online], vol.29, issue.6, pp.784-794, 2014.

M. M. Mcdermott, P. Greenland, K. Liu, and J. M. Guralnik, Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment, JAMA, vol.286, issue.13, pp.1599-1606, 2001.

K. M. Mctigue, Y. Chang, C. Eaton, and L. Garcia, Severe obesity, heart disease, and death among white, African American, and Hispanic postmenopausal women, Obesity (Silver Spring, Md.). [Online], vol.22, issue.3, pp.801-810, 2014.

M. Sibai, A. Nasreddine, L. Mokdad, A. H. Adra, and N. , Nutrition transition and cardiovascular disease risk factors in Middle East and North Africa countries: reviewing the evidence, Annals of Nutrition & Metabolism. [Online], vol.57, issue.3-4, pp.193-203, 2010.

N. Mehta, S. Ogendo, and M. Awori, Prevalence, Progression and Associated Risk Factors of Asymptomatic Peripheral Arterial Disease. Annals of African Surgery, p.14, 2017.

S. R. Mehta, J. Tanguay, J. W. Eikelboom, and S. S. Jolly, Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial, Lancet, vol.376, issue.9748, pp.61088-61092, 2010.

J. B. Meigs, R. B. Agostino, P. W. Wilson, and L. A. Cupples, Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study, Diabetes, vol.46, issue.10, pp.1594-1600, 1997.

C. Méjean, M. Droomers, Y. T. Van-der-schouw, and I. Sluijs, The contribution of diet and lifestyle to socioeconomic inequalities in cardiovascular morbidity and mortality, International Journal of Cardiology, vol.168, issue.6, pp.5190-5195, 2013.

C. Members, E. Braunwald, E. M. Antman, and J. W. Beasley, ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction-2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation, vol.106, pp.1893-1900, 2002.

M. A. Mendall, D. P. Strachan, B. K. Butland, and L. Ballam, C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men, European Heart Journal. [Online], vol.21, pp.1584-1590, 2000.

S. Mendis, P. Puska, B. Norrving, and W. H. Organization, Global atlas on cardiovascular disease prevention and control, 2011.

C. Mestral and S. Stringhini, Socioeconomic Status and Cardiovascular Disease: an Update. Current Cardiology Reports, vol.19, 2017.

S. Mitchell and D. Shaw, The worldwide epidemic of female obesity, Best Practice & Research Clinical Obstetrics & Gynaecology. [Online], vol.29, issue.3, pp.289-299, 2015.

. Moh, General Directorate of PHC Non Communicable Diseases DeptThematic Group Meeting, 2017.

A. H. Mokdad, E. S. Ford, B. A. Bowman, and D. E. Nelson, Diabetes trends in the, Diabetes Care, vol.23, issue.9, pp.1278-1283, 1990.

A. H. Mokdad, M. H. Forouzanfar, F. Daoud, and C. El-bcheraoui, Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet Global Health, vol.4, pp.30168-30169, 2016.

A. H. Mokdad, S. Jaber, M. I. Aziz, and F. Albuhairan, The state of health in the Arab world, 1990-2010: an analysis of the burden of diseases, injuries, and risk factors. The Lancet, vol.383, pp.62189-62192, 2014.

G. Montalescot, S. Achenbach, F. Andreotti, and C. Arden, ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology, European Heart Journal, vol.34, issue.38, pp.2949-3003, 2013.

J. N. Morris and M. D. Crawford, Coronary Heart Disease and Physical Activity of Work, British Medical Journal, vol.2, issue.5111, pp.1485-1496, 1958.

N. J. Morrish, S. Wang, L. K. Stevens, and J. H. Fuller, Mortality and causes of death in the WHO multinational study of vascular disease in diabetes, Diabetologia, vol.44, issue.2, 2001.

D. K. Moser, B. Riegel, S. Mckinley, and L. V. Doering, Impact of anxiety and perceived control on in-hospital complications after acute myocardial infarction. Psychosomatic Medicine, vol.69, pp.10-16, 2007.

B. Motlagh, M. O'donnell, and S. Yusuf, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology, vol.16, issue.3, pp.268-280, 2009.

R. Movva and V. M. Figueredo, Alcohol and the heart: To abstain or not to abstain?, International Journal of Cardiology, vol.172, issue.3, 2014.

D. Mozaffarian, E. J. Benjamin, A. S. Go, and D. K. Arnett, Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the, American Heart Association. Circulation. [Online], vol.133, issue.4, pp.447-454, 2016.

K. W. Muir, Medical Management of Stroke, Neurosurgery & Psychiatry, pp.12-16, 2001.

K. J. Mukamal, C. M. Chen, S. R. Rao, and R. A. Breslow, Alcohol consumption and cardiovascular mortality among U.S. adults, Journal of the American College of Cardiology, vol.55, issue.13, pp.1328-1335, 1987.

K. J. Mukamal, S. E. Chiuve, and E. B. Rimm, Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles. Archives of Internal Medicine, vol.166, pp.2145-2150, 2006.

J. M. Murabito, R. B. Agostino, H. Silbershatz, and W. F. Wilson, Intermittent claudication. A risk profile from The Framingham Heart Study, Circulation, vol.96, issue.1, pp.44-49, 1997.

J. M. Murabito, M. J. Pencina, B. Nam, and R. B. Agostino, Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults, JAMA. [Online], vol.294, issue.24, pp.3117-3123, 2005.

F. Mzayek, Y. Khader, T. Eissenberg, and R. Ali, National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke, Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco, vol.14, issue.4, pp.1581-1587, 2012.

T. S. Nawrot, L. Perez, N. Künzli, and E. Munters, Public health importance of triggers of myocardial infarction: a comparative risk assessment, Lancet, vol.377, issue.9767, pp.62296-62305, 2011.

N. C. , Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report, Circulation, vol.106, issue.25, pp.3143-3421, 2002.

J. Ness, W. S. Aronow, and C. Ahn, Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice, Journal of the American Geriatrics Society, vol.48, issue.3, pp.312-314, 2000.

L. Neubeck, N. Lowres, E. J. Benjamin, and S. B. Freedman, The mobile revolution--using smartphone apps to prevent cardiovascular disease, Nature Reviews, 2015.

, Cardiology, vol.12, issue.6, pp.350-360

S. W. Ng, S. Zaghloul, H. I. Ali, and G. Harrison, The prevalence and trends of overweight, obesity and nutrition-related non-communicable diseases in the Arabian Gulf States. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity, vol.12, pp.1-13, 2011.

N. H. Bp, National High Blood Pressure Education Program Working Group report on primary prevention of hypertension, Archives of Internal Medicine, vol.153, issue.2, pp.186-208, 1993.

B. G. Nordestgaard, M. Benn, P. Schnohr, and A. Tybjaerg-hansen, Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women, JAMA, vol.298, issue.3, pp.299-308, 2007.

B. G. Nordestgaard and A. Varbo, Triglycerides and cardiovascular disease. The Lancet, vol.384, pp.61177-61183, 2014.

B. J. North and D. A. Sinclair, The Intersection Between Aging and Cardiovascular Disease. Circulation Research, vol.110, pp.1097-1108, 2012.

M. Nsour, Z. Mahfoud, M. N. Kanaan, and A. Balbeissi, Prevalence and predictors of nonfatal myocardial infarction in Jordan, vol.14, pp.818-830, 2008.

O. Nygård, S. E. Vollset, H. Refsum, and L. Brattström, Total homocysteine and cardiovascular disease, Journal of Internal Medicine, issue.5, pp.425-454, 1999.

M. J. O'donnell, S. L. Chin, S. Rangarajan, and D. Xavier, Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study, Lancet, vol.388, issue.16, pp.30506-30508, 2016.

, Sex and Gender Aspects in Clinical Medicine, 2012.

. London and . Springer-verlag, , 2018.

, US) & Office on Smoking and Health (US) (2004) The Health Consequences of Smoking: A Report of the Surgeon General. Reports of the Surgeon General, Office of the Surgeon General

(. Atlanta and . Ga, Available from, Centers for Disease Control and Prevention (US), 2018.

P. T. O'gara, F. G. Kushner, D. D. Ascheim, and D. E. Casey, ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, vol.127, 2013.

S. Ojaghihaghighi, S. S. Vahdati, A. Mikaeilpour, and A. Ramouz, Comparison of neurological clinical manifestation in patients with hemorrhagic and ischemic stroke, World Journal of Emergency Medicine, vol.8, issue.1, pp.34-38, 2017.

K. K. Olesen, M. Madsen, G. Egholm, and T. Thim, Patients With Diabetes Without Significant Angiographic Coronary Artery Disease Have the Same Risk of Myocardial Infarction as Patients Without Diabetes in a Real-World Population Receiving Appropriate Prophylactic Treatment. Diabetes Care, pp.1103-1110, 2017.

T. Omland, J. A. De-lemos, M. S. Sabatine, and C. A. Christophi, A sensitive cardiac troponin T assay in stable coronary artery disease, The New England Journal of Medicine, issue.26, pp.2538-2547, 2009.

A. R. Omran, The Epidemiologic Transition: A Theory of the Epidemiology of Population Change. The Milbank Quarterly, vol.83, pp.731-757, 2005.

S. O'neill and L. O'driscoll, Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity, vol.16, pp.1-12, 2015.

W. H. Organization, The World Health Report 2003: Shaping the Future. World Health Organization, 2003.

Y. Ostchega, R. Paulose-ram, C. F. Dillon, and Q. Gu, Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey, Journal of the American Geriatrics Society, vol.55, issue.4, pp.583-589, 1999.

K. Ouriel, Peripheral arterial disease, Lancet, pp.6351-6357, 2001.

O. Oyebode, V. Gordon-dseagu, A. Walker, and J. S. Mindell, Fruit and vegetable consumption and all-cause, cancer and CVD mortality: analysis of Health Survey for England data, J Epidemiol Community Health, vol.68, issue.9, pp.856-862, 2014.

P. J. Palumbo, W. M. O'fallon, P. J. Osmundson, and B. R. Zimmerman, Progression of Peripheral Occlusive Arterial Disease in Diabetes Mellitus: What Factors Are Predictive? Archives of Internal Medicine, vol.151, pp.717-721, 1991.

T. R. Pedersen, J. Kjekshus, K. Berg, and T. Haghfelt, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), Atherosclerosis. Supplements. [Online], vol.5, issue.3, pp.81-87, 1994.

A. Peeters, J. J. Barendregt, F. Willekens, and J. P. Mackenbach, Obesity in adulthood and its consequences for life expectancy: a life-table analysis, Annals of Internal Medicine, vol.138, issue.1, pp.24-32, 2003.

M. J. Pencina, R. B. Agostino, M. G. Larson, and J. M. Massaro, Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation, vol.119, pp.3078-3084, 2009.

J. Perk, Risk factor management: a practice guide, European Journal of Cardiovascular Prevention & Rehabilitation, vol.16, issue.2_suppl, pp.24-28, 2009.

J. Perk, G. De-backer, H. Gohlke, and I. Graham, European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts), European Heart Journal, issue.13, pp.1635-1701, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00927636

S. A. Peters, R. R. Huxley, and M. Woodward, Comparison of the sex-specific associations between systolic blood pressure and the risk of cardiovascular disease: a systematic review and meta-analysis of 124 cohort studies, including 1.2 million individuals. Stroke, vol.44, pp.2394-2401, 2013.

S. A. Peters, R. R. Huxley, and M. Woodward, Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes, Lancet, vol.383, issue.9933, pp.1973-1980, 2014.

, PHIC, 2017.

M. F. Piepoli, A. W. Hoes, S. Agewall, and C. Albus, European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR), European Heart Journal, vol.37, issue.29, pp.2315-2381, 2016.

J. Pineda, F. Marín, P. Marco, and V. Roldán, Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers, International Journal of Cardiology, vol.136, issue.2, pp.222-225, 2009.

P. William, J. Rabinstein, A. A. , A. Teri, A. Opeolu et al., Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, vol.49, pp.46-99, 2018.

W. J. Powers, Acute hypertension after stroke: the scientific basis for treatment decisions, Neurology, vol.43, issue.3, pp.461-467, 1993.

A. M. Prentice, The emerging epidemic of obesity in developing countries, International Journal of Epidemiology, vol.35, issue.1, pp.93-99, 2006.

D. B. Pryor, L. Shaw, C. B. Mccants, and K. L. Lee, Value of the history and physical in identifying patients at increased risk for coronary artery disease, Annals of Internal Medicine, vol.118, issue.2, pp.81-90, 1993.

D. R. Ragland and R. J. Brand, Type A behavior and mortality from coronary heart disease, The New England Journal of Medicine, vol.318, issue.2, pp.65-69, 1988.

H. F. Rahim, A. Sibai, Y. Khader, and N. Hwalla, Non-communicable diseases in the Arab world. The Lancet, vol.383, pp.62383-62384, 2014.

T. M. Ramahi, Cardiovascular Disease in the Asia Middle East Region: Global Trends and Local Implications, Asia Pacific Journal of Public Health, vol.22, issue.3_suppl, pp.83-89, 2010.

R. Ramos, M. García-gil, M. Comas-cufí, and M. Quesada, Statins for Prevention of Cardiovascular Events in a Low-Risk Population With Low Ankle Brachial Index, Journal of the American College of Cardiology, vol.67, issue.6, pp.630-640, 2016.

E. Rapsomaniki, A. Timmis, J. George, and M. Pujades-rodriguez, Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. The Lancet, vol.383, pp.60685-60686, 2014.

V. Regitz-zagrosek, S. Oertelt-prigione, E. Prescott, and F. Franconi, Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes, European Heart Journal. [Online], vol.37, issue.1, pp.24-34, 2016.

P. M. Ridker, Clinical application of C-reactive protein for cardiovascular disease detection and prevention, Circulation, vol.107, issue.3, pp.363-369, 2003.

A. A. Rivellese, G. Riccardi, and O. Vaccaro, Cardiovascular risk in women with diabetes. Nutrition, metabolism, and cardiovascular diseases: NMCD, vol.20, pp.474-480, 2010.

R. Rossi, T. Grimaldi, G. Origliani, and G. Fantini, Menopause and cardiovascular risk. Pathophysiology of Haemostasis and Thrombosis, Online], vol.32, issue.5-6, pp.325-328, 2002.

J. E. Rossouw, R. L. Prentice, J. E. Manson, and L. Wu, Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause, JAMA, vol.297, issue.13, pp.1465-1477, 2007.

G. A. Roth, M. D. Huffman, A. E. Moran, and V. Feigin, Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation, vol.132, pp.1667-1678, 2015.

P. M. Rothwell and C. P. Warlow, Timing of TIAs preceding stroke: time window for prevention is very short, Neurology, vol.64, issue.5, pp.817-820, 2005.

S. Runchey and S. Mcgee, Does this patient have a hemorrhagic stroke?: clinical findings distinguishing hemorrhagic stroke from ischemic stroke, JAMA, issue.22, pp.2280-2286, 2010.

M. S. Sabatine, C. P. Cannon, C. M. Gibson, and J. L. López-sendón, Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation, The New England Journal of Medicine, vol.352, issue.12, pp.1179-1189, 2005.

R. L. Sacco, S. E. Kasner, J. P. Broderick, and L. R. Caplan, An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2013.

. Str,

O. Saidi, M. O&apos;flaherty, N. B. Mansour, and W. Aissi, Forecasting Tunisian type 2 diabetes prevalence to 2027: validation of a simple model, BMC public health, vol.15, 2015.

P. Sakkinen, R. D. Abbott, J. D. Curb, and B. L. Rodriguez, C-reactive protein and myocardial infarction, Journal of Clinical Epidemiology, vol.55, issue.5, pp.445-451, 2002.

Y. Saleem, L. F. Defina, N. B. Radford, and B. L. Willis, Association of a Favorable Cardiovascular Health Profile With the Presence of Coronary Artery CalcificationCLINICAL PERSPECTIVE. Circulation: Cardiovascular Imaging, vol.8, 2015.

F. Sanchis-gomar, C. Perez-quilis, R. Leischik, and A. Lucia, Epidemiology of coronary heart disease and acute coronary syndrome, Available from, p.4, 2016.

A. M. Sarki, C. U. Nduka, S. Stranges, and N. Kandala, Prevalence of Hypertension in Low-and Middle-Income Countries: A Systematic Review and Meta-Analysis. Medicine, vol.94, 2015.

J. Sattelmair, J. Pertman, E. L. Ding, and H. W. Kohl, Dose-Response Between Physical Activity and Risk of Coronary Heart Disease: A Meta-Analysis. Circulation, vol.124, pp.789-795, 2011.

S. Saydah, K. M. Bullard, Y. Cheng, and M. K. Ali, Trends in cardiovascular disease risk factors by obesity level in adults in the United States, Obesity (Silver Spring, Md.). [Online], vol.22, issue.8, pp.1888-1895, 1999.

A. Seita, A. Khader, Y. Shahin, and M. Hababeeh, UNRWA Health Annual Report, 2016.

E. Selvin and T. P. Erlinger, Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, vol.110, pp.738-743, 1999.

S. Seshadri, A. Beiser, M. Kelly-hayes, and C. S. Kase, The lifetime risk of stroke: estimates from the Framingham Study. Stroke, vol.37, pp.345-350, 2006.

H. D. Sesso, I. M. Lee, J. M. Gaziano, and K. M. Rexrode, Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women, Circulation, vol.104, issue.4, pp.393-398, 2001.

L. Sher, Type D personality: the heart, stress, and cortisol, QJM: An International Journal of Medicine, vol.98, issue.5, pp.323-329, 2005.

T. Shimakawa, P. Sorlie, M. A. Carpenter, and B. Dennis, Dietary Intake Patterns and Sociodemographic Factors in the Atherosclerosis Risk in Communities Study. Preventive Medicine, pp.769-780, 1994.

M. Shojaie, M. Pourahmad, A. Eshraghian, and H. R. Izadi, Fibrinogen as a risk factor for premature myocardial infarction in Iranian patients: A case control study. Vascular Health and Risk Management, vol.5, pp.673-676, 2009.

J. Shu and G. Santulli, Update on peripheral artery disease: Epidemiology and evidencebased facts, Atherosclerosis, vol.275, 2018.

B. Silvia, Revista Española de Cardiología (English Edition), vol.67, pp.738-747, 2014.

M. M. Sirdah, N. A. Laham, and A. S. Abu-ghali, Prevalence of metabolic syndrome and associated socioeconomic and demographic factors among Palestinian adults (20-65 years) at the Gaza Strip. Diabetes & Metabolic Syndrome, Online], vol.5, issue.2, pp.93-97, 2011.

A. M. Smith and K. I. Baghurst, Public health implications of dietary differences between social status and occupational category groups, Journal of Epidemiology & Community Health, vol.46, issue.4, pp.409-416, 1992.

J. N. Smith, J. M. Negrelli, M. B. Manek, and E. M. Hawes, Diagnosis and Management of Acute Coronary Syndrome: An Evidence-Based Update, The Journal of the American Board of Family Medicine, vol.28, issue.2, pp.283-293, 2015.

A. Smyth, K. K. Teo, S. Rangarajan, and M. O&apos;donnell, Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: a prospective cohort study, Lancet, vol.386, pp.1945-1954, 2015.

S. Spencer, Global Cardiology Science & Practice, 2014.

M. Stahre, J. Roeber, D. Kanny, and R. D. Brewer, Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States. Preventing Chronic Disease, 2014.

J. S. Stamler and A. Slivka, Biological chemistry of thiols in the vasculature and in vascular-related disease, Nutrition Reviews, vol.54, issue.1, pp.1-30, 1996.

J. J. Stec, H. Silbershatz, G. H. Tofler, and T. H. Matheney, Association of Fibrinogen With Cardiovascular Risk Factors and Cardiovascular Disease in the Framingham Offspring Population. Circulation, vol.102, pp.1634-1638, 2000.

D. Stokols, K. R. Pelletier, and J. E. Fielding, The Ecology of Work and Health: Research and Policy Directions for the Promotion of Employee Health , The Ecology of Work and Health: Research and Policy Directions for the Promotion of Employee Health. Health Education Quarterly, vol.23, pp.137-158, 1996.

N. J. Stone, J. Robinson, A. H. Lichtenstein, and C. N. Merz, ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 2013.

M. Stramba-badiale, K. M. Fox, S. G. Priori, and P. Collins, Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology, European Heart Journal. [Online], vol.27, issue.8, pp.994-1005, 2006.

K. Szummer, L. Wallentin, L. Lindhagen, and J. Alfredsson, Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014, European Heart Journal, vol.38, issue.41, pp.3056-3065, 2017.

I. Tabas, G. García-cardeña, and G. K. Owens, Recent insights into the cellular biology of atherosclerosis, J Cell Biol, vol.209, issue.1, pp.13-22, 2015.

A. Tailakh, L. S. Evangelista, J. C. Mentes, and N. A. Pike, Hypertension prevalence, awareness, and control in Arab countries: A systematic review. Nursing & health sciences, vol.16, pp.126-130, 2014.

H. Tamim, B. Al-sahab, G. Akkary, and M. Ghanem, Cigarette and nargileh smoking practices among school students in Beirut, Lebanon. American Journal of Health Behavior, pp.56-63, 2007.

E. G. Tangalos, D. Cota, and K. Fujioka, Complex cardiometabolic risk factors: impact, assessment, and emerging therapies, Journal of the American Medical Directors Association, vol.7, issue.7, pp.1-10, 2006.

. Task, . Esc, G. Montalescot, U. Sechtem, and S. Achenbach, ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology, European Heart Journal, vol.34, issue.38, pp.2949-3003, 2013.

K. Teo, C. K. Chow, M. Vaz, and S. Rangarajan, The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries, American Heart Journal. [Online], vol.158, issue.1, pp.1-7, 2009.

V. J. Teodorescu, A. K. Vavra, and M. R. Kibbe, Peripheral arterial disease in women, 18S-26S. Available from, vol.57, 2013.

, Aging, menopause, cardiovascular disease and HRT, The Writing Group on behalf of the Workshop Consensus Group, vol.12, pp.368-377, 2009.

C. Thomopoulos, G. Parati, and A. Zanchetti, Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials, Journal of Hypertension, vol.32, issue.12, pp.2285-2295, 2014.

S. G. Thompson, J. Kienast, S. D. Pyke, and F. Haverkate, Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group, The New England Journal of Medicine, vol.332, issue.10, pp.635-641, 1995.

K. Thygesen, J. S. Alpert, A. S. Jaffe, and B. R. Chaitman, Fourth universal definition of myocardial infarction, European Heart Journal. [Online], vol.40, issue.3, pp.237-269, 2018.

K. Thygesen, J. S. Alpert, A. S. Jaffe, and M. L. Simoons, Third universal definition of myocardial infarction. Global Heart, vol.7, pp.275-295, 2012.

A. Toma, G. Paré, and D. P. Leong, Alcohol and Cardiovascular Disease: How Much is Too Much? Current Atherosclerosis Reports, vol.19, 2017.

P. P. Tóth, D. Potter, and E. E. Ming, Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey, Journal of Clinical Lipidology, vol.6, issue.4, pp.325-330, 2003.

T. Truelsen and N. Nielsen, Self-reported stress and risk of stroke: the Copenhagen City Heart Study. Stroke, vol.34, pp.856-862, 2003.

C. W. Tsao and R. S. Vasan, Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology, International Journal of Epidemiology, issue.6, pp.1800-1813, 2015.

M. Turner, M. Barber, H. Dodds, and D. Murphy, Implementing a simple care bundle is associated with improved outcomes in a national cohort of patients with ischemic stroke. Stroke, vol.46, pp.1065-1070, 2015.

G. Turrell, B. Hewitt, C. Patterson, and B. Oldenburg, Measuring socio-economic position in dietary research: is choice of socio-economic indicator important? Public Health Nutrition, vol.6, pp.191-200, 2003.

A. A. Uijen and E. H. Van-de-lisdonk, Multimorbidity in primary care: prevalence and trend over the last 20 years. The European Journal of General Practice, pp.28-32, 2008.

C. Usta and A. Bedel, Update on pharmacological treatment of acute coronary syndrome without persistent ST segment elevation myocardial infarction in the elderly, Journal of Geriatric Cardiology : JGC, vol.14, issue.7, pp.457-464, 2017.

X. Ustrell-roig and J. Serena-leal, , 2007.

, Revista Espanola De Cardiologia, vol.60, issue.7, pp.753-769

P. Verhoef and M. J. Stampfer, Prospective Studies of Homocysteine and Cardiovascular Disease, Nutrition Reviews, vol.53, issue.10, pp.283-288, 1995.

T. Wang and J. Butany, Pathogenesis of atherosclerosis. Diagnostic Histopathology, pp.473-478, 2017.

W. Wang, B. Jiang, H. Sun, and X. Ru, Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480 687 Adults. Circulation, vol.135, pp.759-771, 2017.

J. F. Whelan, M. H. Barry, and J. D. Moir, Color flow Doppler ultrasonography: comparison with peripheral arteriography for the investigation of peripheral vascular disease, Journal of clinical ultrasound: JCU, vol.20, issue.6, pp.369-374, 1992.

P. K. Whelton, R. M. Carey, W. S. Aronow, and D. E. Casey, , p.2017, 2017.

/. Acc/aha/aapa/abc/acpm/ags/apha and . Ash/aspc/nma/pcna, Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

, HYP.0000000000000065. Available from

P. K. Whelton, R. M. Carey, W. S. Aronow, and D. E. Casey, , p.2017, 2018.

/. Acc/aha/aapa/abc/acpm/ags/apha and . Ash/aspc/nma/pcna, Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, Hypertension, issue.6, pp.1269-1324, 1979.

, Global Recommendations on Physical Activity for Health. WHO Guidelines Approved by the Guidelines Review Committee, WHO, 2010.

G. , , p.29, 2018.

, World Health Organization, WHO, p.11, 2017.

, Prevention of cardiovascular disease : pocket guidelines for assessment and management of cardiovascular risk : (WHO/ISH cardiovascular risk prediction charts for the European Region), WHO, 2007.

, WHO (2017b) WHO | Cardiovascular diseases (CVDs), 2017.

, WHO hypertension (2015) WHO | Q&As on hypertension, p.9, 2015.

S. O. Who, New updated WHO classification of BMI (Body Mass Index) « PG Blazer, PG Blazer. Available, p.11, 2004.

, WHO 2014 (n.d.) GLOBAL STATUS REPORT on noncommunicable diseases, 2014.

. Who and . Emro, Noncommunicable diseases in the Eastern Mediterranean Region -Recherche Google, 2016.

, WHO | Risk factors, WHO Global health risk, 2009.

, WHO Global Observatory for eHealth (2011) mHealth: new horizons for health through mobile technologies: second global survey on eHealth, 2018.

W. H. Who, A global brief on hypertension : silent killer, global public health crisis: World Health Day, p.23, 2013.

. Who/gpa, WHO | Global Action Plan for the Prevention and Control of NCDs, 2013.

. Wikipedia, Framingham Risk Score. Wikipedia, 2018.

. Wikipedia, , 2017.

W. C. Willett, A. Green, M. J. Stampfer, and F. E. Speizer, Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes, The New England Journal of Medicine, issue.21, pp.1303-1309, 1987.

P. W. Wilson, W. B. Kannel, H. Silbershatz, and R. B. D&apos;agostino, Clustering of metabolic factors and coronary heart disease, Archives of Internal Medicine, vol.159, issue.10, pp.1104-1109, 1999.

, Tobacco: totally avoidable risk factor of CVD. World Heart Federation, World Heart Federtion, 2017.

D. Xu, J. Li, L. Zou, and Y. Xu, Sensitivity and specificity of the ankle-brachial index to diagnose peripheral artery disease: a structured review, Vascular Medicine. [Online], vol.15, issue.5, pp.361-369, 2010.

Q. Yang, M. E. Cogswell, W. D. Flanders, and Y. Hong, Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults, JAMA, issue.12, pp.1273-1283, 2012.

P. W. Yoon, M. T. Scheuner, K. L. Peterson-oehlke, and M. Gwinn, Can family history be used as a tool for public health and preventive medicine?, Genetics in Medicine: Official Journal of the American College of Medical Genetics, vol.4, issue.4, pp.304-310, 2002.

Z. Yu, A. Nissinen, E. Vartiainen, and G. Song, Associations between socioeconomic status and cardiovascular risk factors in an urban population in China. Bulletin of the World Health Organization, vol.78, pp.1296-1305, 2000.

H. R. Yusuf, W. H. Giles, J. B. Croft, and R. F. Anda, Impact of multiple risk factor profiles on determining cardiovascular disease risk. Preventive Medicine, vol.27, pp.1-9, 1998.

S. Yusuf, S. Hawken, S. Ounpuu, and T. Dans, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, Lancet, vol.364, issue.9438, pp.937-952, 2004.

S. Yusuf, S. Islam, C. K. Chow, and S. Rangarajan, Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey, Lancet, vol.378, issue.9798, pp.61215-61219, 2011.

R. K. Zeidan, R. Farah, M. N. Chahine, and R. Asmar, Prevalence and correlates of coronary heart disease: first population-based study in Lebanon. Vascular Health and Risk Management, vol.12, pp.75-84, 2016.

Z. J. Zheng, W. D. Rosamond, L. E. Chambless, and F. J. Nieto, Lower extremity arterial disease assessed by ankle-brachial index in a middle-aged population of African Americans and whites: The Atherosclerosis, 2005.

, American Journal of Preventive Medicine, issue.5, pp.42-49

L. Zynia, R. Andrew, and C. , THE BURDEN OF DISEASE IN THE WEST BANK AND GAZA AN ASSESSMENT REPORT, 2000.

, Annexes Appendix 1. Questionnaire used during data collection

, Appendix 2. International Physical activity (short English version)

, International Physical activity (short Arabic version)

, Perceived stress scale of Cohen (English version)

, Perceived Stress Scale of Cohen: (Arabic version)

, Complete WHO Rose Angina questionnaire (English version)

, Appendix 7. Complete WHO Rose Angina questionnaire (Arabic version)

, Appendix 10. Locality in Gaza Governorate and population estimation, 2016.

, Locality in Khan Yunis Governorate and population estimation, p.210, 2016.

, Locality Rafah Governorate and population estimation 2016

, Appendix 13. Locality Deir al Balah (mid Gaza) Governorate and population estimation 2016

, Locality North Gaza Governorate and population estimation 2016

, Méthodes : En 2017, une étude transversale utilisant un échantillon de grappes stratifiées a été menée conformément à l'approche STEP de l'OMS. Un échantillon de 2240 participants âgés de ?25 ans ont participé à l'étude. Résultats : La prévalence de la maladie coronarienne est de 8,3 %, AVC est de 3,0 %, l'hypertension artérielle est retrouvée avec une prévalence de 28,4 %, le diabète 19,1 % et l'obésité 47,8 % (60% chez les femmes). L'artériopathie oblitérante des membres inférieurs (AOMI) est observé avec une prévalence de 13,7 %. La prévalence augmente avec l'âge. Elle est plus élevée chez les femmes que chez les hommes (15,6% vs 11,6% respectivement). L'hypertension artérielle et le diabète sont les facteurs associés les plus importants. Le syndrome métabolique est présent avec une prévalence de 41 % plus élevé chez les femmes que chez les hommes (50 % vs 39 %) et associé de façon significative à toutes les maladies cardiovasculaires, Epidemiology of Cardiovascular disease and associated risk factors in Gaza Strip-Palestine Introduction : Les pays arabes du Moyen-Orient qui ont une prédominance de population jeune ont connu des changements socio-économiques rapides, une instabilité et une transition épidémiologique, vol.3, 2018.

. Mots-clés, Also, the burden of risk factors is worrying; one quarter of adult population was hypertensives, tobacco smoking exceeds 30% in males, obesity is alarming mainly in females, and 9.2% of adults are living with diabetes. Very few community-based on CVD studies were conducted in these countries. Methods: In 2017 a cross-sectional study using stratified cluster sample, was conducted in accordance with WHO's STEP wise. A sample of 2240 participants aged ?25 years participated in the study. Results: The prevalence of CAD is 8.3%, stroke 3.0%, hypertension is found with a prevalence of 28.4%, diabetes19.1% and obesity 47.8% with higher rate in females (60%), Maladies cardiovasculaires, facteurs de risques, bande de Gaza-Palestine Epidemiology of Cardiovascular disease and associated risk factors in Gaza Strip-Palestine Introduction: Arab Middle East Countries which have a predominance of young population have undergone rapid socioeconomic changes, instability and epidemiologic transition, vol.3, 2018.